Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science.

Literature DB >> 18604578

Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science.

J Compston¹, D M Reid, J Boisdron, M-L Brandi, N Burlet, D Cahall, P D Delmas, W Dere, J-P Devogelaer, L A Fitzpatrick, B Flamion, N Goel, S Korte, A Laslop, B Mitlak, S Ormarsdottir, J Ringe, R Rizzoli, Y Tsouderos, T Van Staa, J-Y Reginster.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2008 PMID： 18604578 DOI： 10.1007/s00198-008-0670-7

Source DB: PubMed Journal: Osteoporos Int ISSN： 0937-941X Impact factor: 4.507

× No keyword cloud information.

20 in total

Review 1. Bone histomorphometry in glucocorticoid-induced osteoporosis.

Authors: D W Dempster
Journal: J Bone Miner Res Date: 1989-04 Impact factor: 6.741

Review 2. Recommendations for the registration of agents to be used in the prevention and treatment of glucocorticoid-induced osteoporosis: updated recommendations from the Group for the Respect of Ethics and Excellence in Science.

Authors: Eric C Abadie; Jean-Pierre Devogealer; Johann D Ringe; Dominique J Ethgen; Gilles M Bouvenot; Gottfried Kreutz; Andrea Laslop; John J Orloff; Philippe M Vanderauwera; Pierre D Delmas; Willard H Dere; Jaime Branco; Roy D Altman; Bernard P Avouac; Charles J Menkes; Luc Vanhaelst; Bruce H Mitlak; Yannis Tsouderos; Jean-Yves L Reginster
Journal: Semin Arthritis Rheum Date: 2005-08 Impact factor: 5.532

3. Recommendations for the registration of agents used in the prevention and treatment of glucocorticoid-induced osteoporosis.

Authors: J E Compston; M Audran; B Avouac; G Bouvenot; J Devogelaer; R Eastell; F Fabris; C Gennari; E A Jones; J M Kaufman; E Lemmel; G Mazzuoli; D M Reid; J D Ringe; L Vanhaelst; R Ziegler; J Y Reginster
Journal: Calcif Tissue Int Date: 1996-11 Impact factor: 4.333

4. Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

Authors: S Cohen; R M Levy; M Keller; E Boling; R D Emkey; M Greenwald; T M Zizic; S Wallach; K L Sewell; B P Lukert; D W Axelrod; A A Chines
Journal: Arthritis Rheum Date: 1999-11

5. Alendronate for the treatment of osteoporosis in men.

Authors: E Orwoll; M Ettinger; S Weiss; P Miller; D Kendler; J Graham; S Adami; K Weber; R Lorenc; P Pietschmann; K Vandormael; A Lombardi
Journal: N Engl J Med Date: 2000-08-31 Impact factor: 91.245

Review 6. Use of oral corticosteroids and risk of fractures.

Authors: T P Van Staa; H G Leufkens; L Abenhaim; B Zhang; C Cooper
Journal: J Bone Miner Res Date: 2000-06 Impact factor: 6.741

7. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.

Authors: K G Saag; R Emkey; T J Schnitzer; J P Brown; F Hawkins; S Goemaere; G Thamsborg; U A Liberman; P D Delmas; M P Malice; M Czachur; A G Daifotis
Journal: N Engl J Med Date: 1998-07-30 Impact factor: 91.245

8. The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis.

Authors: E S Orwoll; W H Scheele; S Paul; S Adami; U Syversen; A Diez-Perez; J M Kaufman; A D Clancy; G A Gaich
Journal: J Bone Miner Res Date: 2003-01 Impact factor: 6.741

9. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.

Authors: T P Van Staa; R F Laan; I P Barton; S Cohen; D M Reid; C Cooper
Journal: Arthritis Rheum Date: 2003-11

Review 10. Review of the safety and efficacy of risedronate for the treatment of male osteoporosis.

Authors: Raja Bobba; Jonathan D Adachi
Journal: Clin Interv Aging Date: 2007 Impact factor: 4.458

12 in total

1. The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).

Authors: O Bruyere; J A Kanis; M-E Ibar-Abadie; N Alsayed; M L Brandi; N Burlet; D L Cahall; A Chines; J-P Devogelaer; W Dere; N Goel; N Hughes; J-M Kaufman; S Korte; B H Mitlak; D Niese; R Rizzoli; L C Rovati; J-Y Reginster
Journal: Osteoporos Int Date: 2010-03-18 Impact factor: 4.507

2. Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission.

Authors: C M Bastos; I M Araújo; M H Nogueira-Barbosa; C E G Salmon; F J A de Paula; L E A Troncon
Journal: Osteoporos Int Date: 2017-04-12 Impact factor: 4.507

Review 3. Glucocorticoid-induced osteoporosis.

Authors: Stuart L Silverman; Nancy E Lane
Journal: Curr Osteoporos Rep Date: 2009-03 Impact factor: 5.096

4. Glucocorticoid-induced osteoporosis: treatment update and review.

Authors: Lisa-Ann Fraser; Jonathan D Adachi
Journal: Ther Adv Musculoskelet Dis Date: 2009-04 Impact factor: 5.346

Review 5. Management of glucocorticoid-induced osteoporosis.

Authors: Juliet Compston
Journal: Nat Rev Rheumatol Date: 2010-02 Impact factor: 20.543

6. Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice.

Authors: T Thomas; S Horlait; J D Ringe; A Abelson; D T Gold; P Atlan; J L Lange
Journal: Osteoporos Int Date: 2012-06-27 Impact factor: 4.507

Review 7. A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis.

Authors: S Lekamwasam; J D Adachi; D Agnusdei; J Bilezikian; S Boonen; F Borgström; C Cooper; A Diez Perez; R Eastell; L C Hofbauer; J A Kanis; B L Langdahl; O Lesnyak; R Lorenc; E McCloskey; O D Messina; N Napoli; B Obermayer-Pietsch; S H Ralston; P N Sambrook; S Silverman; M Sosa; J Stepan; G Suppan; D A Wahl; J E Compston
Journal: Osteoporos Int Date: 2012-03-21 Impact factor: 4.507